(Q56880809)

2

0 references

author name string

V. Hutse

3

0 references

M. Aerts

4

0 references

P. Van Damme

Long-term persistence of antibodies after one or two doses of MMR-vaccine.

5

0 references

language of work or name

English

0 references

publication date

March 2011

0 references

published in

Vaccine

0 references

volume

29

0 references

issue

11

0 references

page(s)

2222-2226

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Effect of maternal antibodies on the infant immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Early waning of maternal measles antibodies in era of measles elimination: longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella immunity. Defining the level of protective antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella susceptibility among pregnant women in North London, 1996-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Seroprevalence of rubella in school girls and pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The prevalence of anti-rubella antibodies in women of childbearing age in Poland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella seroprevalence in women in the reproductive period, Mersin, Turkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella immunity and vaccination coverage of the population of northern Greece in 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Duration of humoral immunity to common viral and vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Vaccination in the neonatal period and early infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Susceptibility to varicella in childbearing age women, Central Italy: Is there a need for vaccinating this population group?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The incidence of shingles and its implications for vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004

The incidence of herpes zoster in a United States administrative database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.004